PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $10,000 | -9.1% | 3,554 | 0.0% | 0.00% | – |
Q4 2021 | $11,000 | -86.9% | 3,554 | -70.4% | 0.00% | – |
Q3 2021 | $84,000 | +50.0% | 12,012 | +98.7% | 0.00% | – |
Q2 2021 | $56,000 | -5.1% | 6,045 | 0.0% | 0.00% | – |
Q1 2021 | $59,000 | -7.8% | 6,045 | -2.5% | 0.00% | – |
Q4 2020 | $64,000 | +3.2% | 6,203 | 0.0% | 0.00% | – |
Q3 2020 | $62,000 | -22.5% | 6,203 | -19.2% | 0.00% | – |
Q2 2020 | $80,000 | +25.0% | 7,681 | +1.3% | 0.00% | – |
Q1 2020 | $64,000 | -17.9% | 7,584 | -15.2% | 0.00% | – |
Q4 2019 | $78,000 | -7.1% | 8,945 | +15.1% | 0.00% | – |
Q3 2019 | $84,000 | -58.0% | 7,773 | -50.5% | 0.00% | – |
Q2 2019 | $200,000 | -64.9% | 15,712 | +7.2% | 0.00% | – |
Q1 2019 | $569,000 | +90.3% | 14,657 | 0.0% | 0.00% | – |
Q4 2018 | $299,000 | -34.7% | 14,657 | +46.8% | 0.00% | – |
Q3 2018 | $458,000 | -24.3% | 9,981 | -2.4% | 0.00% | – |
Q2 2018 | $605,000 | -17.2% | 10,226 | -4.8% | 0.00% | -100.0% |
Q1 2018 | $731,000 | -41.8% | 10,744 | -15.3% | 0.00% | 0.0% |
Q4 2017 | $1,256,000 | -11.0% | 12,688 | +6.9% | 0.00% | 0.0% |
Q3 2017 | $1,411,000 | +53.7% | 11,865 | +13.1% | 0.00% | 0.0% |
Q2 2017 | $918,000 | +165.3% | 10,490 | +12.8% | 0.00% | – |
Q1 2017 | $346,000 | +24.9% | 9,297 | +2.8% | 0.00% | – |
Q4 2016 | $277,000 | -27.5% | 9,048 | +51.7% | 0.00% | – |
Q3 2016 | $382,000 | +108.7% | 5,963 | -2.9% | 0.00% | – |
Q2 2016 | $183,000 | +144.0% | 6,142 | +142.4% | 0.00% | – |
Q1 2016 | $75,000 | -23.5% | 2,534 | +102.4% | 0.00% | – |
Q4 2015 | $98,000 | -90.1% | 1,252 | -90.5% | 0.00% | -100.0% |
Q3 2015 | $990,000 | +8.8% | 13,142 | +68.7% | 0.00% | 0.0% |
Q2 2015 | $910,000 | -5.9% | 7,791 | +89.3% | 0.00% | 0.0% |
Q1 2015 | $967,000 | +48.3% | 4,116 | +19.8% | 0.00% | 0.0% |
Q4 2014 | $652,000 | -25.6% | 3,435 | -4.2% | 0.00% | 0.0% |
Q3 2014 | $876,000 | – | 3,584 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
Leap Investments LP | 29,100 | $370,000 | 0.50% |
Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |